Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xiaolan Dai"'
Autor:
Jie Li, Ning Han, Zhengyuan He, Xiaolan Dai, Feifei Zhao, Yangyang Li, Wenguang Xiong, Zhenling Zeng
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2349 (2024)
The emergence of plasmid-mediated colistin resistance threatens the efficacy of colistin as a last-resort antibiotic used to treat infection caused by Gram-negative bacteria (GNB). Given the shortage of new antibiotics, the discovery of adjuvants to
Externí odkaz:
https://doaj.org/article/1c088bf763114c74afb5f1a99a5ea3f8
Autor:
Ning Han, Jie Li, Feifei Zhao, Yangyang Li, Jun Wang, Xiaolan Dai, Dongping Zeng, Wenguang Xiong, Zhenling Zeng
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7354 (2023)
Streptococcus suis, an encapsulated zoonotic pathogen, has been reported to cause a variety of infectious diseases, such as meningitis and streptococcal-toxic-shock-like syndrome. Increasing antimicrobial resistance has triggered the need for new tre
Externí odkaz:
https://doaj.org/article/f6724da0984f4ecba696d2c5ea569136
Autor:
Sai-Ching J. Yeung, Gabriel N. Hortobagyi, Francisco J. Esteva, Aiham Z. Qdaisat, Xiaolan Dai, Jiali Ji, Xuexin He
Supplementary Data from Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c9140e08abdcc6ef8d696a411dd245
https://doi.org/10.1158/1078-0432.22481421
https://doi.org/10.1158/1078-0432.22481421
Autor:
Sai-Ching J. Yeung, Gabriel N. Hortobagyi, Francisco J. Esteva, Aiham Z. Qdaisat, Xiaolan Dai, Jiali Ji, Xuexin He
Purpose:Breast cancer and cardiovascular (CV) diseases often share the same risk factors. It is increasingly important to identify risk factors for CV events in patients with high-risk breast cancer and explore optimal treatment regimens.Experimental
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c04257415e695bdcf30adc482f52326d
https://doi.org/10.1158/1078-0432.c.6530691.v1
https://doi.org/10.1158/1078-0432.c.6530691.v1
Autor:
Xuexin He, Xiaolan Dai, Francisco J. Esteva, Aiham Qdaisat, Sai Ching J. Yeung, Jiali Ji, Gabriel N. Hortobagyi
Publikováno v:
Clinical Cancer Research. 27:5343-5352
Purpose: Breast cancer and cardiovascular (CV) diseases often share the same risk factors. It is increasingly important to identify risk factors for CV events in patients with high-risk breast cancer and explore optimal treatment regimens. Experiment
Publikováno v:
Cancer Management and Research. 11:2729-2737
Long non-coding RNAs (lncRNAs) have shown potential as a biomarker in the diagnosis and prognosis in multiple cancers. LncRNAs are dysregulated in various cancers, playing either oncogenic or tumor suppressive roles. Emerging evidences have proved th
Publikováno v:
Clinical breast cancer. 22(1)
Background The combination of trastuzumab with anthracycline chemotherapy drugs is associated with synergistic cardiotoxicity. The aim of this study is to compare the efficacy and late-onset cardiac toxicity of neoadjuvant chemotherapy regimens, tras
Publikováno v:
Oncology Letters
In order to compare the clinicopathological characteristics and survival outcomes of patients with ovarian clear cell carcinoma (CCC) to other epithelial cancer types, a total of 27,290 patients were analyzed, including 2,424 patients with CCC (8.9%)
Publikováno v:
Cancer Management and Research
Long non-coding RNAs (lncRNAs) have shown potential as a biomarker in the diagnosis and prognosis in multiple cancers. LncRNAs are dysregulated in various cancers, playing either oncogenic or tumor suppressive roles. Emerging evidences have proved th
Autor:
Chongjian Wang, Jiali Ji, Xiaolan Dai, Xuexin He, Hong Liu, Francisco J. Esteva, Rongrong Dong, Sai Ching J. Yeung
Publikováno v:
Breast cancer research and treatment. 173(2)
Metaplastic breast cancer (MpBC) is a rare histological subtype of breast cancer recognized as a unique pathologic entity in 2000. However, the pathogenesis, optimal therapy, and prognosis of MpBC and the potential effect of systemic treatments on di